Back to
JACOBS LEVY EQUITY MANAGEMENT, INC
RYTM
Showing 0 of 4 quarters
Position history for
JACOBS LEVY EQUITY MANAGEMENT, INC's holdings in RHYTHM PHARMACEUTICALS INC
No. Jacobs Levy Equity Management exited its RYTM (Rhythm Pharmaceuticals) position in Q3 2022. Its Q2 2022 13F listed 378,714 shares worth $1.6M. Jacobs Levy Equity Management first reported RYTM in Q3 2019 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.